We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the "Bile Acid Code".
- Authors
Gadaleta, Raffaella Maria; Cariello, Marica; Crudele, Lucilla; Moschetta, Antonio
- Abstract
Bile acid (BA) species and the gut microbiota (GM) contribute to intestinal mucosa homeostasis. BAs shape the GM and, conversely, intestinal bacteria with bile salt hydrolase (BSH) activity modulate the BA pool composition. The mutual interaction between BAs and intestinal microorganisms also influences mucosal barrier integrity, which is important for inflammatory bowel disease (IBD) pathogenesis, prevention and therapy. High levels of secondary BAs are detrimental for the intestinal barrier and increase the intestinal inflammatory response and dysbiosis. Additionally, a lack of BSH-active bacteria plays a role in intestinal inflammation and BA dysmetabolism. Thus, BSH-competent bacteria in probiotic formulations are being actively studied in IBD. At the same time, studies exploring the modulation of the master regulator of BA homeostasis, the Farnesoid X Receptor (FXR), in intestinal inflammation and how this impacts the GM are gaining significant momentum. Overall, the choice of probiotic supplementation should be a peculiar issue of personalized medicine, considering not only the disease but also the specific BA and metabolic signatures of a given patient.
- Subjects
THERAPEUTIC use of probiotics; HOMEOSTASIS; INFLAMMATORY bowel diseases; INFLAMMATION; GUT microbiome; HYDROLASES; DIETARY supplements; BILE acids; BACTERIA
- Publication
Nutrients, 2022, Vol 14, Issue 15, p3212
- ISSN
2072-6643
- Publication type
Article
- DOI
10.3390/nu14153212